Literature DB >> 2493850

Anticoagulants in venous thromboembolism.

M D Stringer, N Wilson, V V Kakkar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2493850      PMCID： PMC1835477          DOI： 10.1136/bmj.298.6667.185

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

Authors:  R D Hull; G E Raskob; J Hirsh; R M Jay; J R Leclerc; W H Geerts; D Rosenbloom; D L Sackett; C Anderson; L Harrison
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

2.  [The rectus femoris muscle--the beginning tendon, its functional significance].

Authors:  M Doskocil; M Med; T Vimmer
Journal:  Acta Chir Orthop Traumatol Cech       Date:  1987-04       Impact factor: 0.531

Review 3.  Anticoagulants in venous thromboembolism.

Authors:  A Fennerty; I A Campbell; P A Routledge
Journal:  BMJ       Date:  1988-11-19

4.  An objective study of alternative methods of heparin administration.

Authors:  P G Bentley; V V Kakkar; M F Scully; I R MacGregor; P Webb; P Chan; N Jones
Journal:  Thromb Res       Date:  1980 Apr 1-15       Impact factor: 3.944

5.  Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial.

Authors:  M G Walker; J W Shaw; G J Thomson; J G Cumming; M L Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

6.  Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

Authors:  D J Doyle; A G Turpie; J Hirsh; C Best; D Kinch; M N Levine; M Gent
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

7.  Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis.

Authors:  G Andersson; B Fagrell; K Holmgren; H Johnsson; B Ljungberg; E Nilsson; S Wilhelmsson; S Zetterquist
Journal:  Thromb Res       Date:  1982-09-15       Impact factor: 3.944
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.